80 related articles for article (PubMed ID: 28271660)
1. Prognostic value of human papillomavirus 16/18 genotyping in low-grade cervical lesions preceded by mildly abnormal cytology.
Ye J; Cheng B; Cheng YF; Yao YL; Xie X; Lu WG; Cheng XD
J Zhejiang Univ Sci B; 2017 Mar.; 18(3):249-255. PubMed ID: 28271660
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of HPV 16/18 genotyping and geminin mRNA quantification in low-grade cervical squamous intraepithelial lesion.
Zheng Z; Yang X; Yao X; Li L
Bioengineered; 2021 Dec; 12(2):11482-11489. PubMed ID: 34874226
[TBL] [Abstract][Full Text] [Related]
3. Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.
Bukowski A; Hoyo C; Hudgens MG; Brewster WR; Valea F; Bentley RC; Vidal AC; Maguire RL; Schmitt JW; Murphy SK; North KE; Smith JS
Cancer Epidemiol Biomarkers Prev; 2022 Aug; 31(8):1564-1571. PubMed ID: 35654413
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.
Mu-Mu-Shwe ; Harano T; Okada S; Aye-Aye-Win ; Khin-Saw-Aye ; Hlaing-Myat-Thu ; Mo-Mo-Win ; Khin-Khin-Oo ; Myo-Khin
Acta Med Okayama; 2014; 68(2):79-87. PubMed ID: 24743783
[TBL] [Abstract][Full Text] [Related]
5. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP
J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of genotyping for HPV16 and 18 to triage women with low-grade squamous intraepithelial lesions: a pooled analysis of VALGENT studies.
Xu L; Benoy I; Cuschieri K; Poljak M; Bonde J; Arbyn M
Expert Rev Mol Diagn; 2019 Jun; 19(6):543-551. PubMed ID: 31035813
[No Abstract] [Full Text] [Related]
7. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
8. HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions.
Vrdoljak-Mozetič D; Krašević M; Verša Ostojić D; Štemberger-Papić S; Rubeša-Mihaljević R; Bubonja-Šonje M
Cytopathology; 2015 Feb; 26(1):10-8. PubMed ID: 24261348
[TBL] [Abstract][Full Text] [Related]
9. Preliminary outcomes of the Cervical Cancer Screening Program of Northern Portugal: A snapshot.
Salta S; Sequeira JP; Lobo J; Sousa A; Sousa H; Baldaque I; Monteiro P; Tavares F; Henrique R; Jerónimo C
J Infect Public Health; 2024 Jun; 17(6):1057-1064. PubMed ID: 38705058
[TBL] [Abstract][Full Text] [Related]
10. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
[TBL] [Abstract][Full Text] [Related]
11. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Intaraphet S; Siriaunkgul S
J Med Virol; 2016 Jan; 88(1):135-43. PubMed ID: 26129775
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions.
Cuzick J; Thomas Cox J; Zhang G; Einstein MH; Stoler M; Trupin S; Behrens CM
Int J Cancer; 2013 Feb; 132(4):959-66. PubMed ID: 22806936
[TBL] [Abstract][Full Text] [Related]
13. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
Castle PE; Reid J; Dockter J; Getman D
J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
[TBL] [Abstract][Full Text] [Related]
14. Methylation in Predicting Progression of Untreated High-grade Cervical Intraepithelial Neoplasia.
Louvanto K; Aro K; Nedjai B; Bützow R; Jakobsson M; Kalliala I; Dillner J; Nieminen P; Lorincz A
Clin Infect Dis; 2020 Jun; 70(12):2582-2590. PubMed ID: 31344234
[TBL] [Abstract][Full Text] [Related]
15. Immediate histopathologic correlation in Turkish population with negative cytology and high-risk human papillomavirus positivity: A retrospective analysis of high-risk human papillomavirus genotype and stratified by age.
Kir G; Gunel H; Cicek T; Seneldir H
Diagn Cytopathol; 2023 Oct; 51(10):605-611. PubMed ID: 37318782
[TBL] [Abstract][Full Text] [Related]
16. The effect of local photodynamic therapy with 5-aminolevulinic acid for the treatment of cervical low-grade squamous intraepithelial lesions with high-risk HPV infection: A retrospective study.
Gu L; Cheng M; Hong Z; Di W; Qiu L
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102172. PubMed ID: 33401023
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesion cytology, and its immediate risk for high-grade cervical lesion or cancer: a single-center, cross-sectional study.
Jareemit N; Horthongkham N; Therasakvichya S; Viriyapak B; Inthasorn P; Benjapibal M; Achariyapota V; Ruengkhachorn I
Obstet Gynecol Sci; 2022 Jul; 65(4):335-345. PubMed ID: 35443558
[TBL] [Abstract][Full Text] [Related]
18. Independent prognostic role of human papillomavirus genotype in cervical cancer.
Hang D; Jia M; Ma H; Zhou J; Feng X; Lyu Z; Yin J; Cui H; Yin Y; Jin G; Hu Z; Shen H; Zhang K; Li N; Dai M
BMC Infect Dis; 2017 Jun; 17(1):391. PubMed ID: 28583086
[TBL] [Abstract][Full Text] [Related]
19. Multimodal Hyperspectroscopic Imaging for Detection of High-Grade Cervical Intraepithelial Neoplasia.
Ebisch RMF; Hermens M; van den Akker PAJ; Massuger LFAG; Melchers WJG; Bekkers RLM
J Low Genit Tract Dis; 2017 Jul; 21(3):166-170. PubMed ID: 28403024
[TBL] [Abstract][Full Text] [Related]
20. Active expectancy as alternative to treatment for cervical intraepithelial neoplasia grade 2 in women aged 25 to 30 years: ExCIN2-a prospective clinical multicenter cohort study.
Kylebäck K; Ekeryd-Andalen A; Greppe C; Björkenfeldt Havel C; Zhang C; Strander B
Am J Obstet Gynecol; 2022 Nov; 227(5):742.e1-742.e11. PubMed ID: 35777432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
